Deepak Srivastava, MD

Dr. Deepak Srivastava is the Director of the Gladstone Institute of Cardiovascular Disease and Director of the Roddenberry Stem Cell Center at the Gladstone Institutes. Dr. Srivastava focuses on understanding the causes of heart disease and developing novel therapeutics for human cardiac disorders. In particular, his team is working on producing a one-of-a-kind “blueprint” of the heart that identifies the molecular factors necessary to create a functioning heart. His lab has reprogrammed non-muscle cells in a mouse heart directly into cells that function like heart muscle cells – effectively regenerating heart muscle after damage. Using leading-edge stem cell technology, Dr. Srivastava’s lab is also able to conduct “clinical trials in a dish” to better understand how drugs can affect human heart cells. Dr. Srivastava has won numerous awards for his research, and has been elected into the American Society for Clinical Investigation, the American Academy of Arts and Sciences, the American Association for the Advancement of Science, and the Institute of Medicine.